Valsartan
Valsartan is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Valsartan; Generic name: VALSARTAN; Drug class: Angiotensin 2 Receptor Blocker [EPC].
| Brand name | Valsartan |
|---|---|
| Generic name | VALSARTAN |
| Drug class | Angiotensin 2 Receptor Blocker [EPC] |
| Manufacturer | Lifsa Drugs LLC |
| Used for | 1 INDICATIONS & USAGE Valsartan is an angiotensin II receptor blocker (ARB) indicated for: Hypertension in adults and children six years and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions (1.1) Heart failure (NYHA class II-IV); Valsartan oral solution significantly reduces hospitalization for heart failure in patients who are unable to swallow valsartan tablets (1.2) Stable left ventricular failure or left ventricular dysfunction following myocardial infarction; Valsartan oral solution reduces cardiovascular mortality in patients who are unable to swallow valsartan tablets (1.3 |
| Dosage | 2 DOSAGE & ADMINISTRATION Indication Starting Dose Dose Range Target M a i n t e n a n c e Dose* Hypertension- adults (2.1) 40 or 80 mg twice daily 40 -160 mg twice daily --- Hypertension - age 6 to16 years (2.2) 0.65 mg/kg twice daily (up to 40 mg total) 0.65-1.35 mg/kg twice daily (up to 40 mg-160 mg total) --- Heart Failure (2.3) 40 mg twice daily 40 mg-160 mg twice daily 160 mg twice daily Post-Myocardial Infarction (2.4) 20 mg twice daily 20 mg to 160 mg twice daily 160 mg twice daily *as t |
| Warnings | WARNING: FETAL TOXICITY When pregnancy is detected, discontinue Valsartan Oral Solution as soon as possible. (5.1) Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. (5.1) WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue Valsartan Oral Solution as soon as possible. (5.1) Drugs that act directly on the renin-angiotensin system can cause injury and death to the devel |
| Active ingredient(s) | VALSARTAN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=130e1659-9c2d-49ca-9db8-d28aa23fd133 |